Side-by-side comparison of AI visibility scores, market position, and capabilities
World's leading motion/control technology manufacturer with $19.9B FY2024 revenue; $8.8B Meggitt aerospace acquisition 2022; Win Strategy driving 21%+ segment margins; serves 400,000+ customers.
Parker Hannifin is the world's leading diversified manufacturer of motion and control technologies, founded in 1917 by Arthur Parker in Cleveland, Ohio where it remains headquartered, trading on NYSE (PH). The company generated approximately $19.9 billion in revenues for fiscal year 2024 (ending June 30) under CEO Jenny Parmentier, who succeeded Tom Williams in 2023 and continues Parker's Win Strategy—a systematic operational framework targeting organic growth, segment operating margin improvement to 21%+, and earnings growth through the cycle. Parker's 2022 acquisition of Meggitt plc for approximately $8.8 billion was the company's largest transaction, adding an aerospace and defense components specialist with complementary positions in thermal management, sealing, and fire protection systems for commercial and military aircraft.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.